CHE vs CVS · P/E 24, rev $2.43B vs P/E 16, rev $402.07B
Chemed Corp (CHE) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported CHE revenue for 2024-12-31 was $2.43B. Net income was $302.0M. Revenue was up 7.4% from 2023-12-31 to 2024-12-31. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the CHE and CVS stock pages for the full models.
Not investment advice.